Research Center: Relaro Medical Trials
Location: 12655 N. Central Expressway, Suite 230, Dallas, TX 75243
Lead Doctor: Dr. Writtika Roy

Background

Many children and adolescents suffer from depression. While there are a number of depression treatments available, few exist that are specifically designed for children and adolescents.

This clinical trial is studying the safety and efficacy of an investigational drug for the treatment of MDD in children and adolescents.

This study seeks children and teens who currently suffer from major depressive disorder. Participants are required to attend 9 study visits at the research site over a 10 week period and may provide modest compensation  for participating in this study.

Why Participate? 

• Participants may be compensated for participating in this study 
• You and your child may learn more about depression 
• You and your child may take a more active role in their medical care
• You will be helping to advance medical research

Your Rights

• If you/your child decides to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your/your child’s health as it relates to the study.

Who Can Participate?

• Pediatric patients  7-17 years old diagnosed with Major Depressive Disorder or experiencing symptoms of depression
• Must have parental/guardian consent to participate. 
• Able to swallow whole tablets 
• Able to attend 9 study visits at the research site over approximately 10 weeks